MSD Partners, L.P.

Holdings History for ZIOPHARM ONCOLOGY INC - COM (TCRT)

Symbol: TCRT on Nasdaq
Investment type: Equity / COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2024			-0.09%	$0	0	-15,151,516	-100%		Q1 2024
31 Dec 2023		0.09%	0%	$1,071,212	15,151,516	0		$0.07	Q4 2023
31 Dec 2023	call		-100%	$0	0	-7,575,758	-100%		Q4 2023
30 Sep 2023		0.16%	0%	$1,996,970	15,151,516	0		$0.13	Q3 2023
30 Sep 2023	call	100%	0%	$998,485	7,575,758	0		$0.13	Q3 2023
30 Jun 2023		0.71%	0%	$7,727,273	15,151,516	0		$0.51	Q2 2023
30 Jun 2023	call	100%	0%	$3,863,637	7,575,758	0		$0.51	Q2 2023
31 Mar 2023		0.96%	0%	$9,545,455	15,151,516	0		$0.63	Q1 2023
31 Mar 2023	call	2.2%	0%	$4,772,728	7,575,758	0		$0.63	Q1 2023
31 Dec 2022		1.1%	0%	$9,834,849	15,151,516	0		$0.65	Q4 2022
31 Dec 2022	call	3.2%	0%	$4,917,425	7,575,758	0		$0.65	Q4 2022
30 Sep 2022		3%	0%	$26,061,000	15,151,516	0		$1.72	Q3 2022
30 Sep 2022	call	3.6%	0%	$13,030,000	7,575,758	0		$1.72	Q3 2022
30 Jun 2022		1.4%	0%	$18,788,000	15,151,516	0		$1.24	Q2 2022
30 Jun 2022	call	3.2%	0%	$9,394,000	7,575,758	0		$1.24	Q2 2022
31 Mar 2022		0.61%	-1.2%	$9,885,000	15,151,516	-30,303,032	-67%	$0.65	Q1 2022
31 Mar 2022	call	2.2%	+2.2%	$4,942,000	7,575,758	+7,575,758	NEW	$0.65	Q1 2022
31 Dec 2021		0.62%	+0.41%	$49,545,000	45,454,548	+30,303,032	+200%	$1.09	Q4 2021
31 Dec 2021	call		-2.4%	$0	0	-7,575,758	-100%		Q4 2021
30 Sep 2021		1%	0%	$27,576,000	15,151,516	0		$1.82	Q3 2021
30 Sep 2021	call	2.4%	+2.4%	$13,788,000	7,575,758	+7,575,758	NEW	$1.82	Q3 2021
30 Jun 2021		1.3%	0%	$40,000,000	15,151,516	0		$2.64	Q2 2021
31 Mar 2021		2.2%	0%	$54,545,000	15,151,516	0		$3.60	Q1 2021
31 Dec 2020		7.5%	0%	$38,182,000	15,151,516	0		$2.52	Q4 2020
30 Sep 2020		8.5%	0%	$38,182,000	15,151,516	0		$2.52	Q3 2020
30 Jun 2020		13%	0%	$49,697,000	15,151,516	0		$3.28	Q2 2020
31 Mar 2020		10%	0%	$37,121,000	15,151,516	0		$2.45	Q1 2020
31 Dec 2019		16%	0%	$71,515,000	15,151,516	0		$4.72	Q4 2019
30 Sep 2019		11%	+3.1%	$64,848,000	15,151,516	+4,165,258	+38%	$4.28	Q3 2019
30 Jun 2019		8.5%	0%	$64,050,000	10,986,258	0		$5.83	Q2 2019
31 Mar 2019		6.9%	0%	$42,297,000	10,986,258	0		$3.85	Q1 2019
31 Dec 2018		3.2%	+2.2%	$20,544,000	10,986,258	+7,575,758	+222%	$1.87	Q4 2018
30 Sep 2018		1.8%	0%	$10,914,000	3,410,500	0		$3.20	Q3 2018
30 Jun 2018		1.7%	0%	$10,300,000	3,410,500	0		$3.02	Q2 2018
31 Mar 2018		2.1%	0%	$13,369,000	3,410,500	0		$3.92	Q1 2018
31 Dec 2017		2.4%	0%	$14,119,000	3,410,500	0		$4.14	Q4 2017
30 Sep 2017		1.9%	0%	$20,940,000	3,410,500	0		$6.14	Q3 2017
30 Jun 2017		1.4%	0%	$21,213,000	3,410,500	0		$6.22	Q2 2017
31 Mar 2017		1.4%	0%	$21,623,000	3,410,500	0		$6.34	Q1 2017
31 Dec 2016		1.3%	0%	$18,246,000	3,410,500	0		$5.35	Q4 2016
30 Sep 2016		1.6%	0%	$19,201,000	3,410,500	0		$5.63	Q3 2016
30 Jun 2016		1.2%	-0.05%	$18,724,000	3,410,500	-148,000	-4.2%	$5.49	Q2 2016
31 Mar 2016		1.4%	-0.2%	$26,404,000	3,558,500	-500,000	-12%	$7.42	Q1 2016
31 Dec 2015		1.5%	-0.13%	$33,726,000	4,058,500	-350,000	-7.9%	$8.31	Q4 2015
30 Sep 2015		1.4%	-0.02%	$39,721,000	4,408,500	-66,500	-1.5%	$9.01	Q3 2015
30 Jun 2015		1.6%	+0.02%	$53,700,000	4,475,000	+50,000	+1.1%	$12.00	Q2 2015
31 Mar 2015		1.4%	+0.1%	$47,657,000	4,425,000	+305,389	+7.4%	$10.77	Q1 2015
31 Dec 2014		0.75%	+0.25%	$20,886,000	4,119,611	+1,369,611	+50%	$5.07	Q4 2014
30 Sep 2014		0.26%	0%	$7,260,000	2,750,000	0		$2.64	Q3 2014
30 Jun 2014		0.38%	0%	$11,083,000	2,750,000	0		$4.03	Q2 2014
31 Mar 2014		0.49%	0%	$12,595,000	2,750,000	0		$4.58	Q1 2014
31 Dec 2013		0.52%	0%	$11,935,000	2,750,000	0		$4.34	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.